Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides ; volume:72 ; number:8 ; day:24 ; month:5 ; year:2023 ; pages:2851-2864 ; date:8.2023
Cancer immunology immunotherapy ; 72, Heft 8 (24.5.2023), 2851-2864, 8.2023
- Urheber
-
Stegmann, Toon
Wiekmeijer, Anna-Sophia
Kwappenberg, Kitty
Duikeren, Suzanne van
Bhoelan, Farien
Bemelman, Denzel
Beenakker, Thomas J. M.
Krebber, Willem-Jan
Arens, Ramon
Melief, Cornelis J. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03462-y
- URN
-
urn:nbn:de:101:1-2023102609363390605329
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stegmann, Toon
- Wiekmeijer, Anna-Sophia
- Kwappenberg, Kitty
- Duikeren, Suzanne van
- Bhoelan, Farien
- Bemelman, Denzel
- Beenakker, Thomas J. M.
- Krebber, Willem-Jan
- Arens, Ramon
- Melief, Cornelis J. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
HPV16 mutant E6/E7 construct is protective in mouse model
Assessment of methods to direct T cells toward a newly established HPV16 E6/E7-dependent orthotopic tumor model in A2.DR1 mice
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice
Differential localization of HPV16 E6 splice products with E6-associated protein
Untersuchungen zur Genexpression der E6/E7-Region des humanen Papillomvirus Typ 16 in oralen Tumoren
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens
Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
HPV16 mutant E6/E7 construct is protective in mouse model
Assessment of methods to direct T cells toward a newly established HPV16 E6/E7-dependent orthotopic tumor model in A2.DR1 mice
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice
Differential localization of HPV16 E6 splice products with E6-associated protein
Untersuchungen zur Genexpression der E6/E7-Region des humanen Papillomvirus Typ 16 in oralen Tumoren
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens
Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
HPV16 mutant E6/E7 construct is protective in mouse model
Assessment of methods to direct T cells toward a newly established HPV16 E6/E7-dependent orthotopic tumor model in A2.DR1 mice
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice
Differential localization of HPV16 E6 splice products with E6-associated protein
Untersuchungen zur Genexpression der E6/E7-Region des humanen Papillomvirus Typ 16 in oralen Tumoren
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens